Trials / Conditions / Luminal B
Luminal B
4 registered clinical trials studyying Luminal B.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | A Randomised Trial Comparing Trastuzumab Deruxtecan to CDK4/6 Inhibitors in Non-luminal A, ER-positive/HER2-lo NCT06585969 | Danish Breast Cancer Cooperative Group | Phase 3 |
| Active Not Recruiting | Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, + NCT03875573 | Jules Bordet Institute | Phase 2 |
| Completed | Safety and Efficacy of Durvalumab Combined to Neoadjuvant Chemotherapy in Localized Luminal B HER2(-) and Trip NCT03356860 | Grand Hôpital de Charleroi | Phase 1 / Phase 2 |
| Completed | Effect of Physical Exercise on Tumor Proliferation of Luminal B Breast Cancer Patients NCT03860740 | Spanish Breast Cancer Research Group | — |